跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

安全信息

75423

Millipore

万古霉素添加剂

suitable for microbiology

别名:

Vancomycin 盐酸盐

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C66H75Cl2N9O24 · xHCl
CAS号:
1404-93-9
分子量:
1449.25 (free base basis)
MDL编号:
MFCD00064593
UNSPSC代码:
41171614
NACRES:
NA.85

Agency

according to GB 4789.40-2016
according to ISO 22964:2017

质量水平

200

无菌性

sterile

表单

powder

保质期

limited shelf life, expiry date on the label

应用

environmental
food and beverages
microbiology

储存温度

2-8°C

适用性

Enterobacter spp.

InChI

1S/C66H75Cl2N9O24.ClH/c1-23(2)12-34(71-5)58(88)76-49-51(83)26-7-10-38(32(67)14-26)97-40-16-28-17-41(55(40)101-65-56(54(86)53(85)42(22-78)99-65)100-44-21-66(4,70)57(87)24(3)96-44)98-39-11-8-27(15-33(39)68)52(84)50-63(93)75-48(64(94)95)31-18-29(79)19-37(81)45(31)30-13-25(6-9-36(30)80)46(60(90)77-50)74-61(91)47(28)73-59(89)35(20-43(69)82)72-62(49)92;/h6-11,13-19,23-24,34-35,42,44,46-54,56-57,65,71,78-81,83-87H,12,20-22,70H2,1-5H3,(H2,69,82)(H,72,92)(H,73,89)(H,74,91)(H,75,93)(H,76,88)(H,77,90)(H,94,95);1H/t24-,34+,35-,42+,44-,46+,47+,48-,49+,50-,51+,52+,53+,54-,56+,57+,65-,66-;/m0./s1

InChI key

LCTORFDMHNKUSG-XTTLPDOESA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

应用

ISO 委员会推荐用于选择性增菌阪崎肠杆菌的抗生素添加剂。

组分

（每瓶足够用于 1000mL 培养基）
万古霉素 10.00mg

相关产品

产品编号
说明
价格

象形图

Health hazard
GHS08

警示用语：

Danger

危险声明

H317,H334

危险分类

Resp. Sens. 1 - Skin Sens. 1

储存分类代码

11 - Combustible Solids

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

法规信息

监管及禁止进口产品

从最新的版本中选择一种：

分析证书(COA)

Lot/Batch Number
BCCL3616
BCCK1951
BCCJ6136
BCCH4321
BCCG2227

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Christine Dieterich et al.
Toxicological sciences : an official journal of the Society of Toxicology, 107(1), 258-269 (2008-10-22)
Vancomycin, one of few effective treatments against methicillin-resistant Staphylococcus aureus, is nephrotoxic. The goals of this study were to (1) gain insights into molecular mechanisms of nephrotoxicity at the genomic level, (2) evaluate gene markers of vancomycin-induced kidney injury, and
Klas I Udekwu et al.
The Journal of antimicrobial chemotherapy, 63(4), 745-757 (2009-02-17)
To determine the functional relationship between the density of bacteria and the pharmacodynamics of antibiotics, and the potential consequences of this inoculum effect on the microbiological course of antibiotic treatment of Staphylococcus aureus infections. In vitro time-kill, MIC estimation and
Screening municipal wastewater effluent and surface water used for drinking water production for the presence of ampicillin and vancomycin resistant enterococci
Maja Taucer-Kapteijn
International Journal of Hygiene and Environmental Health, 4-5, 437-442 (2016)
Oliver A Cornely et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(19), 2493-2499 (2013-05-30)
Patients with cancer are at increased risk for Clostridium difficile-associated diarrhea (CDAD). Little is known about treatment response. Two double-blind trials randomly allocated 1,105 patients with CDAD to fidaxomicin or vancomycin treatment (modified intent-to-treat [mITT]), and 183 of these had
Duodenal infusion of feces for recurrent Clostridium difficile.
Bernhard Ramsauer
The New England journal of medicine, 368(22), 2144-2144 (2013-05-31)
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门